Cargando…
Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
ABSTRACT: Probiotics have been considered as an economical and safe alternative for the treatment of a large number of chronic diseases and improvement of human health. They are known to modulate the host immunity and protect from several infectious and non-infectious diseases. The colonization, kil...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749913/ https://www.ncbi.nlm.nih.gov/pubmed/35015145 http://dx.doi.org/10.1007/s00253-021-11646-8 |
_version_ | 1784631342607106048 |
---|---|
author | Yadav, Manoj Kumar Kumari, Indu Singh, Bijender Sharma, Krishna Kant Tiwari, Santosh Kumar |
author_facet | Yadav, Manoj Kumar Kumari, Indu Singh, Bijender Sharma, Krishna Kant Tiwari, Santosh Kumar |
author_sort | Yadav, Manoj Kumar |
collection | PubMed |
description | ABSTRACT: Probiotics have been considered as an economical and safe alternative for the treatment of a large number of chronic diseases and improvement of human health. They are known to modulate the host immunity and protect from several infectious and non-infectious diseases. The colonization, killing of pathogens and induction of host cells are few of the important probiotic attributes which affect several functions of the host. In addition, prebiotics and non-digestible food substances selectively promote the growth of probiotics and human health through nutrient enrichment, and modulation of gut microbiota and immune system. This review highlights the role of probiotics and prebiotics alone and in combination (synbiotics) in the modulation of immune system, treatment of infections, management of inflammatory bowel disease and cancer therapy. KEY POINTS: • Probiotics and their derivatives against several human diseases. • Prebiotics feed probiotics and induce several functions in the host. • Discovery of novel and biosafe products needs attention for human health. |
format | Online Article Text |
id | pubmed-8749913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-87499132022-01-11 Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics Yadav, Manoj Kumar Kumari, Indu Singh, Bijender Sharma, Krishna Kant Tiwari, Santosh Kumar Appl Microbiol Biotechnol Mini-Review ABSTRACT: Probiotics have been considered as an economical and safe alternative for the treatment of a large number of chronic diseases and improvement of human health. They are known to modulate the host immunity and protect from several infectious and non-infectious diseases. The colonization, killing of pathogens and induction of host cells are few of the important probiotic attributes which affect several functions of the host. In addition, prebiotics and non-digestible food substances selectively promote the growth of probiotics and human health through nutrient enrichment, and modulation of gut microbiota and immune system. This review highlights the role of probiotics and prebiotics alone and in combination (synbiotics) in the modulation of immune system, treatment of infections, management of inflammatory bowel disease and cancer therapy. KEY POINTS: • Probiotics and their derivatives against several human diseases. • Prebiotics feed probiotics and induce several functions in the host. • Discovery of novel and biosafe products needs attention for human health. Springer Berlin Heidelberg 2022-01-11 2022 /pmc/articles/PMC8749913/ /pubmed/35015145 http://dx.doi.org/10.1007/s00253-021-11646-8 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Mini-Review Yadav, Manoj Kumar Kumari, Indu Singh, Bijender Sharma, Krishna Kant Tiwari, Santosh Kumar Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics |
title | Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics |
title_full | Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics |
title_fullStr | Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics |
title_full_unstemmed | Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics |
title_short | Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics |
title_sort | probiotics, prebiotics and synbiotics: safe options for next-generation therapeutics |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749913/ https://www.ncbi.nlm.nih.gov/pubmed/35015145 http://dx.doi.org/10.1007/s00253-021-11646-8 |
work_keys_str_mv | AT yadavmanojkumar probioticsprebioticsandsynbioticssafeoptionsfornextgenerationtherapeutics AT kumariindu probioticsprebioticsandsynbioticssafeoptionsfornextgenerationtherapeutics AT singhbijender probioticsprebioticsandsynbioticssafeoptionsfornextgenerationtherapeutics AT sharmakrishnakant probioticsprebioticsandsynbioticssafeoptionsfornextgenerationtherapeutics AT tiwarisantoshkumar probioticsprebioticsandsynbioticssafeoptionsfornextgenerationtherapeutics |